Baldassarre Damiano, De Jong Arienne, Amato Mauro, Werba J Pablo, Castelnuovo Samuela, Frigerio Beatrice, Veglia Fabrizio, Tremoli Elena, Sirtori Cesare R
E. Grossi Paoletti Center, Department of Pharmacological Sciences, University of Milan, Italy.
Ann Med. 2008;40(1):21-44. doi: 10.1080/07853890701645399.
Different soluble molecules involved in inflammation, endothelial damage, or hemostasis are recognized as potential cardiovascular risk markers. Studies to assess the role of these markers in the atherosclerotic process by evaluating their relationship to carotid intima-media thickness (C-IMT) tend to provide contrasting results.
To perform a review of studies addressing the association between C-IMT and soluble markers and to investigate whether the observed inconsistencies could be explained by the characteristics of the patients included in different studies, for example prevalence of atherosclerotic disease (atherosclerotic burden), gender, age, or occurrence of specific vascular risk factors (VRFs).
PubMed and Embase (January 1990 to March 2006).
Articles in English reporting original cross-sectional studies.
Two authors independently extracted data on study design, population, sample size, ultrasonic methodology, and statistical approach.
Despite the marked heterogeneity of results presented in the literature, meta-analysis established that studies showing positive associations between C-IMT and plasma levels of C-reactive protein (CRP) or fibrinogen are in the majority. Funnel plot analyses suggested the absence of an important publication bias. Data on the relationships between C-IMT and other soluble markers are by contrast scanty, contradictory, or unconfirmed by multivariate (as opposed to univariate) analyses, and the freedom from publication bias here cannot be vouched for. The degree of atherosclerotic burden in the population studied does not account for the heterogeneity of findings reported. Gender, noninsulin-dependent diabetes mellitus (NIDDM) and hypercholesterolemia influence the association between C-IMT and CRP. Blood pressure and hypercholesterolemia influence the association between C-IMT and fibrinogen. For all the other soluble markers considered, the number of groups was too small for this kind of statistical considerations.
Heterogeneity in ultrasound methodologies and in statistical approach limited comparability between studies. For most soluble markers, publication bias of positive results cannot be excluded.
Only CRP and fibrinogen seem to be unequivocally related to C-IMT. For all the other soluble markers considered, no clear-cut conclusions can be drawn.
参与炎症、内皮损伤或止血过程的不同可溶性分子被视为潜在的心血管风险标志物。通过评估这些标志物与颈动脉内膜中层厚度(C-IMT)之间的关系来评估其在动脉粥样硬化进程中作用的研究往往得出相互矛盾的结果。
对探讨C-IMT与可溶性标志物之间关联的研究进行综述,并调查观察到的不一致性是否可以用不同研究中纳入患者的特征来解释,例如动脉粥样硬化疾病的患病率(动脉粥样硬化负担)、性别、年龄或特定血管危险因素(VRF)的存在情况。
PubMed和Embase(1990年1月至2006年3月)。
报告原始横断面研究的英文文章。
两位作者独立提取关于研究设计、人群、样本量、超声方法和统计方法的数据。
尽管文献中呈现的结果存在显著异质性,但荟萃分析表明,显示C-IMT与C反应蛋白(CRP)或纤维蛋白原血浆水平呈正相关的研究占多数。漏斗图分析表明不存在重要的发表偏倚。相比之下,关于C-IMT与其他可溶性标志物之间关系的数据较少、相互矛盾或未得到多变量(与单变量相对)分析的证实,且无法保证不存在发表偏倚。所研究人群中的动脉粥样硬化负担程度并不能解释所报告结果的异质性。性别、非胰岛素依赖型糖尿病(NIDDM)和高胆固醇血症会影响C-IMT与CRP之间的关联。血压和高胆固醇血症会影响C-IMT与纤维蛋白原之间的关联。对于所考虑的所有其他可溶性标志物,由于分组数量过少,无法进行此类统计考量。
超声方法和统计方法的异质性限制了研究之间的可比性。对于大多数可溶性标志物,不能排除阳性结果的发表偏倚。
只有CRP和纤维蛋白原似乎与C-IMT明确相关。对于所考虑的所有其他可溶性标志物,无法得出明确结论。